What are the typical clinical findings and presentation of Ebstein anomaly in a newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Presentation of Ebstein Anomaly in Newborns

Neonates with Ebstein anomaly present with cardiomegaly, congestive heart failure, and cyanosis, typically within the first 3 days of life, with 20-40% mortality within the first month if symptomatic. 1

Clinical Presentation

Cardinal Features at Birth

The typical newborn with Ebstein anomaly presents with:

  • Cyanosis (80% of cases) - the most common presenting feature 2
  • Cardiomegaly - present in 95% of cases on chest X-ray 3
  • Congestive heart failure with respiratory distress
  • Acidosis (mean pH 7.20) and severe hypoxemia (mean PaO₂ ~30 mmHg) 4
  • Prostaglandin E1 dependence due to functional pulmonary atresia 4

Physical Examination Findings

Cardiovascular signs:

  • Systolic murmur (86% of cases) - holosystolic at lower left sternal border 3
  • Low cardiac output manifesting as poor peripheral perfusion
  • Subtle or absent right ventricular lift despite severe pathology 5
  • Loud first heart sound with possible systolic clicks 5
  • Jugular venous pressure often normal despite severe tricuspid regurgitation (due to compliant, enlarged right atrium) 5

Pathophysiology in Neonates

The severe neonatal presentation results from:

  1. Massive tricuspid regurgitation with functional pulmonary atresia
  2. Inability of right ventricle to generate forward flow through pulmonary arteries
  3. Persistent elevated pulmonary vascular resistance in early neonatal period
  4. Circular shunt physiology - blood flows from right atrium → left atrium → left ventricle → aorta → patent ductus arteriosus → pulmonary arteries 6

Diagnostic Workup

Echocardiography (Diagnostic Test of Choice)

Key echocardiographic findings: 5

  • Apical displacement of septal and posterior tricuspid leaflets below the AV junction
  • Atrialization of right ventricular inflow
  • Massive right atrial enlargement
  • Severe tricuspid regurgitation
  • Redundancy, tethering, and fenestrations of anterior leaflet
  • Functional pulmonary atresia (pulmonary valve not opening) 4

Severity grading (grades 1-4 based on ratio of right atrium + atrialized RV area to functional RV + left heart area):

  • Grade 3-4 carries 44-100% cardiac mortality 2
  • Echocardiographic grade is the best independent predictor of death 2

Chest X-Ray

  • Massive cardiomegaly - mean cardiothoracic ratio 0.81 4
  • "Globular" cardiac contour with prominent right atrial enlargement 5, 7
  • Clear lung fields
  • Small or inconspicuous great arteries 5

Electrocardiogram

  • Right bundle branch block pattern (76% of cases) 3
  • Right atrial enlargement (62% of cases) 3
  • Tall, peaked P waves ("Himalayan P waves") 5
  • QR pattern in V1 extending to V4 5
  • Prolonged, "splintered" QRS with inverted T waves 5
  • Possible Wolff-Parkinson-White pattern (25% have accessory pathways) 5

Associated Lesions (Present in 54% of Cases)

  • Atrial septal defect or patent foramen ovale (>50% of patients) - causes right-to-left shunting and cyanosis 5
  • Pulmonary stenosis (in 11 patients) or pulmonary atresia (in 7 patients) 2
  • Ventricular septal defect 5
  • Right ventricular outflow tract obstruction 5

Prognostic Factors

Poor Prognostic Indicators 6, 2, 3

Clinical factors:

  • Presentation in first days of life
  • Onset of cyanosis in infancy
  • Severe congestive heart failure requiring mechanical ventilation
  • Inability to wean from prostaglandin E1

Anatomic/hemodynamic factors:

  • Echocardiographic grade 3-4 severity
  • Lower insertion of septal tricuspid leaflet
  • Higher ratio of RA + atrialized RV to functional RV + left heart
  • Associated pulmonary stenosis or atresia
  • Cardiothoracic ratio >65% 1
  • Severe cardiomegaly and RV dysfunction 8

Natural History

Critical early mortality: 1, 2

  • 20-40% of symptomatic neonates die within first month
  • <50% survive to 5 years if presenting in neonatal period
  • Actuarial survival at 10 years: 61% 2

Spontaneous improvement possible: Some neonates improve as pulmonary vascular resistance falls during the first week of life 1

Management Approach

Initial Stabilization 6

  • Prostaglandin E1 to maintain ductal patency
  • Mechanical ventilation if needed
  • Correction of acidosis
  • Consider urgent PDA closure (surgical or catheter-based) if RVSP is adequate to reduce circular shunt burden

Surgical Timing 8, 6

For critically ill neonates:

  • Starnes procedure (tricuspid valve closure with fenestrated patch + aortopulmonary shunt) for those with severe RV dysfunction and functional pulmonary atresia 6, 4
  • Conversion to biventricular repair or continued single-ventricle staging at 3-5 months 6

For stable but symptomatic neonates:

  • Defer definitive repair to 3-5 months when pulmonary vascular resistance has fallen 6
  • Consider ductal stent or BT shunt as bridge if prostaglandin-dependent 6

Key Surgical Principle

Avoid "cut-and-sew" tricuspid valve repair in early neonatal period when pulmonary vascular resistance remains elevated - defer to 3-5 months for simplified repair or cone reconstruction 6

Common Pitfalls

  1. Underestimating severity - jugular venous pressure may appear normal despite severe TR due to compliant right atrium 5
  2. Premature valve surgery - attempting complex repair before PVR falls increases mortality 6
  3. Missing associated lesions - always evaluate for ASD/PFO, accessory pathways, and RVOT obstruction 5
  4. Delayed recognition - cyanosis in first 3 days of life with massive cardiomegaly should prompt immediate echocardiography 2, 3

References

Research

Outcome in neonates with Ebstein's anomaly.

Journal of the American College of Cardiology, 1992

Research

Factors affecting mortality in Ebstein's anomaly of the tricuspid valve.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1999

Research

Ebstein's anomaly appearing in the neonate. A new surgical approach.

The Journal of thoracic and cardiovascular surgery, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.